Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Cardiol Therapeutics Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 1 | 20 | +19 |
| Shares | 1.13M | 2.64M | +1.51M (+133.2%) |
| Value | $3.37M | $12.0M | +$8.63M (+256.3%) |
New holders (19)
Institutions that held Cardiol Therapeutics Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 1,043,704 | $4.30M | 0.01% |
| Renaissance Technologies LLC | 144,900 | $598.0K | 0.00% |
| Jane Street Group, LLC | 79,431 | $327.0K | 0.00% |
| Virtu Financial LLC | 75,819 | $315.0K | 0.03% |
| Geode Capital Management, LLC | 52,435 | $217.0K | 0.00% |
| Vident Investment Advisory, LLC | 50,566 | $208.0K | 0.01% |
| Two Sigma Advisers, LP | 31,100 | $129.0K | 0.00% |
| Morgan Stanley | 27,090 | $112.0K | 0.00% |
| Marble Harbor Investment Counsel, LLC | 22,000 | $91.0K | 0.01% |
| Goldman Sachs Group Inc | 19,100 | $79.0K | 0.00% |
| Advisor Group Holdings, Inc. | 15,800 | $65.0K | 0.00% |
| Royal Bank of Canada | 14,195 | $59.0K | 0.00% |
| Bank of America Corp | 13,808 | $57.0K | 0.00% |
| Federation des caisses Desjardins du Quebec | 6,000 | $24.5K | 0.00% |
| Private Ocean, LLC | 5,500 | $23.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,161 | $9.00K | 0.00% |
| Toronto Dominion Bank | 882 | $4.00K | 0.00% |
| Piscataqua Savings Bank | 1,000 | $4.00K | 0.00% |
| Tradewinds Capital Management, LLC | 500 | $2.00K | 0.00% |
Sold out (0)
Institutions that held Cardiol Therapeutics Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.